Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias

Publisher： Karger

E-ISSN： 1421-9824|31|1|37-44

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.31, Iss.1, 2010-12, pp. : 37-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Bacterial Contamination and the Transport Vial Material Affect Cerebrospinal Fluid Concentrations of β-Amyloid and Tau Protein as Determined by Enzyme Immunoassay

By  

Dementia and Geriatric Cognitive Disorders, Vol. 32, Iss. 2, 2011-09 ,pp. : 126-134

Karger

Access to resources Recommend Favorite

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-08 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 1-2, 2013-07 ,pp. : 99-110

Karger

Access to resources Recommend Favorite

Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 5, 2009-05 ,pp. : 474-480

Karger

Access to resources Recommend Favorite